the invention relates to u0431u0438u043eu043cu0430u0440u043au0435u0440u0430u043c for detection sensitivity and high adaptation to hypoxia and how to obtain them.the invention, in particular,refers to the gene variants SNP id rs479200 and rs480902 first u0438u043du0442u0440u043eu043du0435 gene EGLN1 (u043fu0440u043eu043bu0438u043bu0433u0438u0434u0440u043eu043au0441u0438u043bu0430u0437u044b 2) as u0431u0438u043eu043cu0430u0440u043au0435u0440u043eu0432 adaptation to high altitude and u043fu0440u0435u0434u0440u0430u0441u043fu043eu043bu043eu0436u0435u043du043du043eu0441 t to a high-altitude edemalight and sensitivity to hypoxia.the use of which provides a new approach to the application of the concepts of u0444u0435u043du043eu0442u0438u043fu0438u0440u043eu0432u0430u043du0438u044f according to u0430u044eu0440u0432u0435u0434u0435 together with population genetics and gene u043eu043cu0438u043au043eu0439 diseases.more specifically, the - allel SNP id rs480902 and t - allel rs479200 gene EGLN1u0447u0430u0449u0435 occur in patients with u043du0430u0440u0435 (high-altitude edema) and virtually absent from the natives u0440u043du043eu0439 areas.according to the present invention also proposed u043fu0440u0430u0439u043cu0435u0440u044b and methods suitable for the detection of these u0430u043bu043bu0435u043bu044cu043du044bu0445 optionsin order to predict the individual adaptability to high altitude hypoxia and / or to the genetic analysis of the gene EGLN1u0432 populations.
展开▼
